Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

176.21 +3.06 (+1.77%)
Official Closing Price Updated: 4:10 PM EDT, Jul 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,114,970
Open 173.20
Bid (Size) 175.80 (1)
Ask (Size) 176.50 (1)
Prev. Close 173.15
Today's Range 172.95 - 176.60
52wk Range 135.85 - 182.89
Shares Outstanding N/A
Dividend Yield 3.36%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio
With political rumblings poised to make things exciting, investors may turn to the stability of trustworthy dividend stocks. 
Via InvestorPlace
AbbVie Earnings Preview: Will Humira's Expiry, New CEO Fuel A Bullish Surge?
AbbVie will report Q2 earnings on Thursday. Investors watch for Humira impact and signs of recovery under new CEO. 
Via Benzinga

Performance

YTD
+10.26%
+10.26%
1 Month
+2.01%
+2.01%
3 Month
+3.93%
+3.93%
6 Month
+5.20%
+5.20%
1 Year
+23.07%
+23.07%

More News

Read More
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
Via The Motley Fool
10 Best Dividend Growth Stocks to Buy and Hold Forever
Via The Motley Fool
7 High-Yield Dividend Stocks to Help Pay Your Bills
Via InvestorPlace
AbbVie Unusual Options Activity
Via Benzinga
AbbVie Unusual Options Activity
Via Benzinga
$1000 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
Via Benzinga
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
Via Benzinga
3 Absurdly Cheap Stocks to Buy and Hold for Years
Via The Motley Fool
7 High-Yield Dividend Stocks Beating Inflation
Via InvestorPlace
Topics Economy
Exposures Interest Rates
3 Quantum AI Stocks That Could Redefine Computing
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Recession-Proof Stocks to Shield Your Portfolio in 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Spinoff Stocks You Should Buy Now: July 2024
Via InvestorPlace
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Via The Motley Fool
3 Dividend Growth Stocks to Buy and Hold
Via The Motley Fool
3 High-Yield Dividend Stocks That Still Look Like Bargains
Via The Motley Fool
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
Via Benzinga
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Via Benzinga
Topics Cannabis
Exposures Cannabis
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
Via MarketBeat
The 7 Best Warren Buffett Stocks to Buy in July 2024
Via InvestorPlace
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.